Understanding Your Diagnosis: Primary Familial Brain Calcification
At a Glance
Primary familial brain calcification is an inherited condition that causes calcium deposits in the basal ganglia and other brain regions. Scan findings do not reliably predict symptoms, so diagnosis and follow-up focus on clinical health, ruling out secondary causes, and individualized care.
Receiving a diagnosis of Primary Familial Brain Calcification (PFBC) can feel overwhelming, especially because the condition is rare and often misunderstood [1][2]. You may have heard it called Fahr’s Disease, an older name used to describe the buildup of calcium in specific areas of the brain [3][4]. Note that “Fahr’s disease” can sometimes be confusing because the term “Fahr syndrome” is often used for secondary brain calcification. It is important to know that your experience is valid; because this condition is uncommon, many general practitioners may not have encountered it before, making it essential to work with specialists who understand its complexities [5][6].
What is PFBC?
Primary Familial Brain Calcification (also called Primary Brain Calcification, or PBC) is a genetic condition where calcium deposits form in the brain’s basal ganglia (structures that help control movement) and other regions [7][1]. Unlike other types of brain calcification that might be caused by infections or hormone imbalances, PFBC is “primary,” meaning it is typically rooted in your genetic makeup [5][6]. While it was once thought to be exceptionally rare, newer research estimates radiologic calcification may affect between 2 and 6 out of every 1,000 people, though symptomatic, genetically confirmed PFBC is rarer, and many people never develop symptoms [1][8].
The Gap Between Scans and Symptoms
One of the most important things to understand about PFBC is that your brain scan does not tell your whole story. Doctors often talk about two different ways the disease shows up:
- Imaging Phenotype: This is what shows up on a CT scan or MRI. In people with specific PFBC genes, the “imaging penetrance” (the likelihood that calcification will show up on a scan) has been estimated in some studies as nearly 100% [7][9].
- Clinical Phenotype: This refers to the actual symptoms a person feels, such as movement challenges, mood changes, or memory issues. The “clinical penetrance” (the likelihood of actually feeling sick) is much lower, estimated in a pooled review at about 61% [7][9].
These percentages are research estimates, not predictions of your personal future. Crucially, the volume or amount of calcification seen on your scan does not strictly predict how severe your symptoms will be [7][10]. Some people with extensive calcification remain completely asymptomatic (without symptoms), while others with very small deposits may experience noticeable changes [8][2]. This is why modern guidelines recommend that doctors focus on your clinical well-being rather than just the “spots” on the scan [6][11].
A Highly Variable Journey
PFBC is known for its variable expressivity, which means it can look very different even among members of the same family who have the exact same genetic variant [12][13].
- Age of Onset: Symptoms can begin at almost any age. In common genetic forms, the median age for symptoms to start is around 31, but it can range from early childhood to late adulthood [14][7].
- Incomplete Penetrance: As mentioned, nearly one-third of people with the genetic markers for PFBC never develop clinical symptoms [2][9]. Inheriting a variant does not mean you have a 61% personal risk of symptoms.
- Progression: The disease does not follow a single, predictable path. While calcification may slowly increase over years, your symptoms may stay stable for long periods [11][15].
Why Expertise Matters
Because PFBC is rare, your local doctor may not be familiar with the latest 2025 international consensus guidelines, which propose a framework categorizing the diagnosis as possible, probable, or definite [6]. A specialist, such as a neurogeneticist or a movement disorder specialist, can help confirm that your calcification isn’t caused by a treatable metabolic issue, like a parathyroid disorder, before confirming a PFBC diagnosis [5][16].
Managing PFBC currently focuses on symptom-focused care—treating individual symptoms like headaches, mood changes, or movement issues as they arise—rather than trying to “remove” the calcium [17][18]. Engaging with research registries or specialized clinics can help ensure you are connected to the most current understanding of this unique condition [NCT01793168][NCT05662111]. There is no universally established schedule for imaging asymptomatic relatives, so testing decisions should consider psychosocial and privacy factors.
Common questions in this guide
What is primary familial brain calcification?
Can I have PFBC on a brain scan without having symptoms?
What symptoms can primary familial brain calcification cause?
How do doctors determine whether brain calcification is primary PFBC?
Can treatment remove the calcium deposits caused by PFBC?
What follow-up is needed if I have PFBC but no symptoms?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Bilateral striopallidodentate calcinosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the 2025 international consensus guidelines, how confident are you that my diagnosis is 'primary' rather than secondary to another cause?
- 2.Have we ruled out secondary causes of brain calcification, such as parathyroid issues or metabolic imbalances, through blood tests?
- 3.If I am currently asymptomatic, how frequently should I have follow-up clinical evaluations?
- 4.Can you explain the difference between 'imaging penetrance' and 'clinical penetrance' as it relates to my diagnosis?
References
References (18)
- 1
Estimation of minimal disease prevalence from population genomic data: Application to primary familial brain calcification.
Nicolas G, Charbonnier C, Campion D, Veltman JA
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2018; (177(1)):68-74 doi:10.1002/ajmg.b.32605.
PMID: 29152850 - 2
The Genetics of Primary Familial Brain Calcification: A Literature Review.
Chen SY, Ho CJ, Lu YT, et al.
International journal of molecular sciences 2023; (24(13)) doi:10.3390/ijms241310886.
PMID: 37446066 - 3
Basal ganglia calcification: 'Fahr's disease'.
Magrinelli F, Jesuthasan A, Bhatia KP, Batla A
Practical neurology 2025; (25(6)):520-526 doi:10.1136/pn-2024-004258.
PMID: 40169250 - 4
White matter involvement in a family with a novel PDGFB mutation.
Biancheri R, Severino M, Robbiano A, et al.
Neurology. Genetics 2016; (2(3)):e77 doi:10.1212/NXG.0000000000000077.
PMID: 27227165 - 5
Brain Calcification and Movement Disorders.
Kostić VS, Petrović IN
Current neurology and neuroscience reports 2017; (17(1)):2 doi:10.1007/s11910-017-0710-9.
PMID: 28097511 - 6
Primary Brain Calcification: An International Consensus on Nomenclature, Diagnosis, Evaluation, and Management.
Luo W, Cen Z, Koek H, et al.
Movement disorders : official journal of the Movement Disorder Society 2026; (41(2)):315-336 doi:10.1002/mds.70140.
PMID: 41346103 - 7
Primary familial brain calcification with known gene mutations: a systematic review and challenges of phenotypic characterization.
Tadic V, Westenberger A, Domingo A, et al.
JAMA neurology 2015; (72(4)):460-7 doi:10.1001/jamaneurol.2014.3889.
PMID: 25686319 - 8
Underestimated disease prevalence and severe phenotypes in patients with biallelic variants: A cohort study of primary familial brain calcification from China.
Chen S, Cen Z, Fu F, et al.
Parkinsonism & related disorders 2019; (64()):211-219 doi:10.1016/j.parkreldis.2019.04.009.
PMID: 31003906 - 9
Genotype-Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene Review.
Balck A, Schaake S, Kuhnke NS, et al.
Movement disorders : official journal of the Movement Disorder Society 2021; (36(11)):2468-2480 doi:10.1002/mds.28753.
PMID: 34432325 - 10
Primary familial brain calcifications: genetic and clinical update.
Westenberger A, Balck A, Klein C
Current opinion in neurology 2019; (32(4)):571-578 doi:10.1097/WCO.0000000000000712.
PMID: 31157644 - 11
Novel findings in a Swedish primary familial brain calcification cohort.
Sennfält S, Gustavsson P, Malmgren H, et al.
Journal of the neurological sciences 2024; (460()):123020 doi:10.1016/j.jns.2024.123020.
PMID: 38642488 - 12
Familial Idiopathic Basal Ganglia Calcification: A Father-Son Dyad Demonstrate Heterogeneity of Presentation and Disease Progression.
Zahniser E, Bird TD, Chen DH, et al.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2022; (37(1)):217-225 doi:10.1093/arclin/acab026.
PMID: 33893476 - 13
XPR1: a Gene Linked to Primary Familial Brain Calcification Might Help Explain a Spectrum of Neuropsychiatric Disorders.
Moura DA, Oliveira JR
Journal of molecular neuroscience : MN 2015; (57(4)):519-21 doi:10.1007/s12031-015-0631-5.
PMID: 26231937 - 14
Brain calcification process and phenotypes according to age and sex: Lessons from SLC20A2, PDGFB, and PDGFRB mutation carriers.
Nicolas G, Charbonnier C, de Lemos RR, et al.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2015; (168(7)):586-94 doi:10.1002/ajmg.b.32336.
PMID: 26129893 - 15
CT-based Volume Measurement of Brain Calcification Is Related to Clinical Symptoms and Disease Progression in Primary Familial Brain Calcification.
Snijders BMG, Pierey L, Peters MJL, et al.
Clinical neuroradiology 2026; (36(2)):431-438 doi:10.1007/s00062-025-01595-4.
PMID: 41296026 - 16
Basal Ganglia Calcifications for Nephrologists: Fahr/Primary Familial Brain Calcification (PFBC) at the Interface of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) and Hypoparathyroidism.
Alrashidi FS
Cureus 2025; (17(12)):e99031 doi:10.7759/cureus.99031.
PMID: 41531582 - 17
The clinical and genetic spectrum of primary familial brain calcification.
Carecchio M, Mainardi M, Bonato G
Journal of neurology 2023; (270(6)):3270-3277 doi:10.1007/s00415-023-11650-0.
PMID: 36862146 - 18
Astrocytes in Primary Familial Brain Calcification (PFBC): Emphasis on the Importance of Induced Pluripotent Stem Cell-Derived Human Astrocyte Models.
Kavakli E, Gul N, Begentas OC, Kiris E
Advances in experimental medicine and biology 2025; (1479()):19-38 doi:10.1007/5584_2024_840.
PMID: 39841380
This page explains primary familial brain calcification for informational purposes and does not constitute medical advice. A neurologist or neurogenetics specialist should interpret your scans, test results, and follow-up needs.